Workflow
Vape Carts
icon
Search documents
AYURCANN REPORTS Q1 2026 SALES OF $14,638,697
Globenewswire· 2025-11-28 22:30
Core Insights - Ayurcann Holdings Corp. reported financial and operational results for Q1 2026, highlighting a gross revenue of $14,638,697 and a gross profit of $2,236,343, resulting in a gross margin of 26% [2] - The company is recognized as a Top 3 vape producer in Ontario, holding a 5% share of the national vape market and a 7% share in Ontario [3] - Ayurcann has launched 30 new stock keeping units in the last six months, enhancing its product offerings in vapes, pre-rolls, and concentrates [4] Financial Performance - Gross revenue for Q1 2026 was $14,638,697, a slight decrease from $14,657,485 in Q1 2025 [2] - Gross profit decreased from $3,321,974 in Q1 2025 to $2,236,343 in Q1 2026, indicating a shift in profitability [2] - The gross margin fell from 40% in Q1 2025 to 26% in Q1 2026, reflecting changes in cost structure or pricing strategy [2] Market Position - Ayurcann has established itself as a leading player in the vape segment, contributing to its overall market share and brand recognition [3] - The company is focusing on expanding its distribution network across licensed stores in Canada, strengthening its position as a trusted supplier [5] Operational Efficiency - Ayurcann is recognized for its operational discipline, consistently delivering strong output and quality [4] - The company has demonstrated a commitment to innovation by introducing a significant number of new products in a short timeframe [4]
AYURCANN REPORTS RECORD SALES GROWTH IN Q3 2025 OF $14,179,974 AND PROVIDES CORPORATE UPDATE
Globenewswire· 2025-05-16 12:00
Core Insights - Ayurcann Holdings Corp. reported record-breaking financial results for the three months ended March 31, 2025, showcasing exceptional growth and operational excellence in the cannabis industry [1][2] Financial Performance - Gross revenue for Q3 2025 reached $14,179,974, marking a 22% year-over-year increase from $11,655,360 in Q3 2024 [8] - Positive adjusted EBITDA of $766,742 at the operating subsidiary level and $342,634 on a consolidated basis, with a gross margin of 38% [8] - Consistent gross margins and a disciplined cost structure support sustainable profitability and future shareholder value [6] Market Position - Ayurcann is recognized as a Top 3 vape producer in Ontario by volume, holding a 5% share of the national vape market and an 8% share in Ontario [8] - The company has established itself as one of Canada's most efficient and scalable cannabis producers, with strong market share and growing brand recognition [8] Product Development and Expansion - Over the last six months, Ayurcann launched 25 new SKUs across vapes, pre-rolls, and concentrates, enhancing its product portfolio [8] - The company is actively expanding into additional provinces and retail channels across Canada, which is expected to drive continued revenue growth [7][8] - Ayurcann is scaling its pre-rolls and concentrates to tap into growing consumer segments in the cannabis market [8] Operational Efficiency - The company's lean, high-throughput manufacturing model enables it to maintain strong gross margins and positive cash flow in a competitive pricing environment [8] - Ayurcann's products are now available nationwide, positioning the company as a reliable national supplier to retailers [8]